{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:08Z","timestamp":1793608028558,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129166","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:55:51Z","timestamp":1789667751000},"page":"129166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: a randomized controlled trial"],"prefix":"10.1016","volume":"92","author":[{"given":"Nutchaya","family":"Laoharattanahirun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobporn","family":"Boonnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackrapong","family":"Bruminhent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129166_bb0005","author":"World Health Organization"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129166_bb0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archinte.161.3.441","article-title":"Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome","volume":"161","author":"Lin","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.vaccine.2026.129166_bb0015","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3201\/eid1911.130546","article-title":"Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009\u20132011","volume":"19","author":"Cohen","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129166_bb0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/QAD.0b013e3283434844","article-title":"Severe 2009 pandemic influenza a (H1N1) infection and increased mortality in patients with late and advanced HIV disease","volume":"25","author":"Ormsby","year":"2011","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129166_bb0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/cid\/cit725","article-title":"The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts","volume":"58","author":"Memoli","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2026.129166_bb0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/cid\/ciq110","article-title":"Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature","volume":"52","author":"Sheth","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.vaccine.2026.129166_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007022","article-title":"Mortality after hospitalization for pneumonia among individuals with HIV: a Danish cohort study","volume":"4","author":"S\u00f8gaard","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129166_bb0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(10)70093-1","article-title":"Effect of treating co-infections on HIV-1 viral load: a systematic review","volume":"10","author":"Modjarrad","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129166_bb0045","author":"European Centre for Disease Prevention and Control"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129166_bb0050","article-title":"A systematic review and meta-analysis of seasonal influenza vaccination of health workers","volume":"9","author":"Li","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129166_bb0055","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2024\u201325 influenza season","volume":"73","author":"Center of Disease Control and Prevention","year":"2024","journal-title":"MMWR Recomm. Rep."},{"issue":"19","key":"10.1016\/j.vaccine.2026.129166_bb0060","first-page":"185","article-title":"Recommended composition of influenza virus vaccines for use in the 2022-2023 northern hemisphere influenza season","volume":"97","author":"World Health Organization","year":"2022","journal-title":"Wkly Epidemiol. Rec."},{"issue":"3","key":"10.1016\/j.vaccine.2026.129166_bb0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cid\/civ884","article-title":"Randomized controlled trial to compare immunogenicity of standard-dose intramuscular versus intradermal trivalent inactivated influenza vaccine in HIV-infected men who have sex with men in Bangkok, Thailand","volume":"62","author":"Garg","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2026.129166_bb0070","first-page":"90","article-title":"Immunogenicity of COVID-19 vaccination in PLWH: progress and challenges","volume":"3","author":"Song","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129166_bb0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/21645515.2015.1076599","article-title":"Safety and immunogenicity of influenza vaccine among HIV-infected adults: conventional vaccine vs. intradermal vaccine","volume":"12","author":"Seo","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6","key":"10.1016\/j.vaccine.2026.129166_bb0080","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jama.1989.03430060075029","article-title":"The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine","volume":"262","author":"Miotti","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.129166_bb0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7326\/0003-4819-109-5-383","article-title":"HIV infection and influenza vaccine responses","volume":"109","author":"Nelson","year":"1988","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.vaccine.2026.129166_bb0090","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cit937","article-title":"Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis","volume":"58","author":"Kern\u00e9is","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.vaccine.2026.129166_bb0095","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1080\/21645515.2021.1983387","article-title":"Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized phase III trial","volume":"17","author":"Pepin","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129166_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-158-1-201301010-00005","article-title":"Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial","volume":"158","author":"McKittrick","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129166_bb0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/cid\/ciad477","article-title":"Immunogenicity of high-dose versus MF59-adjuvanted versus standard influenza vaccine in solid organ transplant recipients: the Swiss\/Spanish trial in solid organ transplantation on prevention of influenza (STOP-FLU trial)","volume":"78","author":"Mombelli","year":"2024","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.vaccine.2026.129166_bb0110","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129166_bb0115","series-title":"Influenza (seasonal) [internet]","author":"World","year":"2023"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129166_bb0120","article-title":"Influenza-associated excess mortality by age, sex, and subtype\/lineage: population-based time-series study with a distributed-lag nonlinear model","volume":"9","author":"Li","year":"2023","journal-title":"JMIR Public Health Surveill."},{"issue":"10","key":"10.1016\/j.vaccine.2026.129166_bb0125","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2026.129166_bb0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/QAI.0000000000003186","article-title":"A prospective immunogenicity study of a quadrivalent inactivated influenza vaccine among persons with HIV with different levels of CD4 cell count","volume":"93","author":"Satanon","year":"2023","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.vaccine.2026.129166_bb0135","series-title":"Recommended composition of influenza virus vaccines for use in the 2023\u20132024 northern hemisphere influenza season [internet]","author":"World Health Organization","year":"2023"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:38:36Z","timestamp":1793605116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S0264410X26009758"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129166","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129166"}}